Sarcomas are not included
  • American Joint Committee on Cancer

Summary of Changes

The definition of TNM and the Stage Grouping for this chapter have not changed from the Fifth Edition.


Squamous Cell Carcinoma Esophageal Cancer Basal Cell Carcinoma Small Cell Carcinoma Pleomorphic Adenoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Block MI, Patterson GA, Sundaresan RS, et al: Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 64:770–777, 1997PubMedCrossRefGoogle Scholar
  2. Casson AG, Rusch VW, Ginsberg RJ, Zankowicz N, Finley RJ: Lymph node mapping of esophageal cancer. Ann Thorac Surg 58:1569–1570, 1994PubMedCrossRefGoogle Scholar
  3. Ellis FH Jr, Heatley GJ, Krasna MJ, Williamson WA, Balogh K: Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg 113:836–848, 1997PubMedCrossRefGoogle Scholar
  4. Kawahara K, Maekawa T, Okabayashi K, et al: The number of lymph node metastases influences survival in esophageal cancer. J Surg Oncol 67:160–163, 1998PubMedCrossRefGoogle Scholar
  5. Kelsen DP, Ginsberg R, Pajak TF, et al: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979–1984, 1998PubMedCrossRefGoogle Scholar
  6. Killinger WA, Jr., Rice TW, Adelstein DJ, et al: Stage II esophageal carcinoma: the significance of T and N. J Thorac Car-diovasc Surg 111:935–940, 1996CrossRefGoogle Scholar
  7. Lightdale CJ: Positron emission tomography: another useful test for staging esophageal cancer. J Clin Oncol 18:3199–3201, 2000PubMedGoogle Scholar
  8. Nishimaki T, Tanaka O, Ando N, et al: Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. Ann Thorac Surg 68:2059–2064, 1999PubMedCrossRefGoogle Scholar
  9. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR: Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterol 104:510–513, 1993Google Scholar
  10. Rudolph RE, Vaughan TL, Storer BE, et al: Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Int Med 132:612–620, 2000PubMedGoogle Scholar
  11. Rusch VW, Levine DS, Haggitt R, Reid BJ: The management of high grade dysplasia and early cancer in Barrett’s esophagus. Cancer 74:1225–1229, 1994PubMedCrossRefGoogle Scholar
  12. Sabik JF, Rice TW, Goldblum JR, et al: Superficial esophageal carcinoma. Ann Thorac Surg 60:896–902, 1995PubMedCrossRefGoogle Scholar
  13. Sampliner RE: Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus: the Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 93:1028–1032, 1998PubMedCrossRefGoogle Scholar
  14. Siewert JR, Feith M, Werner M, Stein HJ: Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Trans Am Surg Assoc 118:67–75, 2000Google Scholar
  15. Steup WH, De Leyn P, Deneffe G, Van Raemdonck D, Coosemans W, Lerut T: Tumors of the esophagogastric junction. Long term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg 111:85–95, 1996PubMedCrossRefGoogle Scholar
  16. Yang PC, Davis S: Incidence of cancer of the esophagus in the U.S. by histologic type. Cancer 61:612–617, 1988PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • American Joint Committee on Cancer
    • 1
  1. 1.Executive OfficeChicagoUSA

Personalised recommendations